Home › Employers › Ridgewood City Pharmacy
Ridgewood City Pharmacy: H-1B salaries and sponsorship
Ridgewood City Pharmacy filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $86,668.
Does Ridgewood City Pharmacy sponsor H-1B visas?
Ridgewood City Pharmacy filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 10, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Regulatory and Compliance Analyst | 4 | $86,668 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $75,629 |
| FY2025 | 3 | $94,806 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Regulatory and Compliance Analyst | $94,806 Level III | Ridgewood, NY | Apr 10, 2025 | Apr 22, 2025 | Certified |
| Regulatory and Compliance Analyst | $94,806 Level III | Ridgewood, NY | Apr 10, 2025 | Apr 22, 2025 | Certified |
| Regulatory and Compliance Analyst | $78,529 Level II | Ridgewood, NY | Apr 8, 2025 | Apr 22, 2025 | Certified |
| Regulatory and Compliance Analyst | $75,629 Level II | Ridgewood, NY | Mar 29, 2023 | Sep 28, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).